However, interferon (IFN)-mediated HCV eradication reduces but does not eliminate the risk of HCC once cirrhosis has been established; in the same conditions, DAA therapy may also not eliminate the risk of HCC. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.